Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications
AbstractThe neutrophil-to-lymphocyte ratio (NLR) is a novel predictive biomarker that reflects systemic inflammatory status and is routinely measured in blood tests. Owing to its ease of use and affordability, it is being increasing used as a prognostic indicator of cardiovascular disease, tumors, a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2259996 |
| _version_ | 1797211823530835968 |
|---|---|
| author | Nan Yang Kaibi Yang Shujun Pan Qiang He Juan Jin |
| author_facet | Nan Yang Kaibi Yang Shujun Pan Qiang He Juan Jin |
| author_sort | Nan Yang |
| collection | DOAJ |
| description | AbstractThe neutrophil-to-lymphocyte ratio (NLR) is a novel predictive biomarker that reflects systemic inflammatory status and is routinely measured in blood tests. Owing to its ease of use and affordability, it is being increasing used as a prognostic indicator of cardiovascular disease, tumors, autoimmune disorders, and kidney disease. In recent years, a number of studies have demonstrated the clinical utility of the NLR in identifying and predicting complications associated with hemodialysis and peritoneal dialysis, including cardiovascular disease and infection. This review aimed to provide a new perspective on the application of the NLR as a valuable tool enabling clinicians to better assess the occurrence and prognosis of complications in patients undergoing dialysis. |
| first_indexed | 2024-03-11T19:59:42Z |
| format | Article |
| id | doaj.art-9b1538bdc3944a778ea52c94406a1b8e |
| institution | Directory Open Access Journal |
| issn | 0886-022X 1525-6049 |
| language | English |
| last_indexed | 2024-04-24T10:32:37Z |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj.art-9b1538bdc3944a778ea52c94406a1b8e2024-04-12T14:34:28ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492023-12-0145210.1080/0886022X.2023.2259996Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complicationsNan Yang0Kaibi Yang1Shujun Pan2Qiang He3Juan Jin4Department of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, ChinaDepartment of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, ChinaDepartment of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, ChinaDepartment of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, ChinaDepartment of Nephrology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang, ChinaAbstractThe neutrophil-to-lymphocyte ratio (NLR) is a novel predictive biomarker that reflects systemic inflammatory status and is routinely measured in blood tests. Owing to its ease of use and affordability, it is being increasing used as a prognostic indicator of cardiovascular disease, tumors, autoimmune disorders, and kidney disease. In recent years, a number of studies have demonstrated the clinical utility of the NLR in identifying and predicting complications associated with hemodialysis and peritoneal dialysis, including cardiovascular disease and infection. This review aimed to provide a new perspective on the application of the NLR as a valuable tool enabling clinicians to better assess the occurrence and prognosis of complications in patients undergoing dialysis.https://www.tandfonline.com/doi/10.1080/0886022X.2023.2259996Neutrophil-to-lymphocyte ratiohemodialysisperitoneal dialysiscomplicationsdisease burden |
| spellingShingle | Nan Yang Kaibi Yang Shujun Pan Qiang He Juan Jin Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications Renal Failure Neutrophil-to-lymphocyte ratio hemodialysis peritoneal dialysis complications disease burden |
| title | Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications |
| title_full | Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications |
| title_fullStr | Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications |
| title_full_unstemmed | Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications |
| title_short | Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications |
| title_sort | progress in the application of the neutrophil to lymphocyte ratio in dialysis related complications |
| topic | Neutrophil-to-lymphocyte ratio hemodialysis peritoneal dialysis complications disease burden |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2023.2259996 |
| work_keys_str_mv | AT nanyang progressintheapplicationoftheneutrophiltolymphocyteratioindialysisrelatedcomplications AT kaibiyang progressintheapplicationoftheneutrophiltolymphocyteratioindialysisrelatedcomplications AT shujunpan progressintheapplicationoftheneutrophiltolymphocyteratioindialysisrelatedcomplications AT qianghe progressintheapplicationoftheneutrophiltolymphocyteratioindialysisrelatedcomplications AT juanjin progressintheapplicationoftheneutrophiltolymphocyteratioindialysisrelatedcomplications |